Stephen J. Freedland

Sort by:

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.

Stephen J. Freedland, Elizabeth B. Humphreys, +4 authors Alan W. Partin
JAMA
2005

CONTEXT The natural history of biochemical recurrence after radical prostatectomy can be long but variable. Better risk assessment models are needed to identify men who are at high risk for prostate… (More)

Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer.

Nancy L. Keating, A. James O'Malley, Stephen J. Freedland, Matthew Raymond Smith
Journal of the National Cancer Institute
2012

Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.

Bruce J. Trock, Misop Han, +4 authors Patrick Walsh
JAMA
2008

CONTEXT Biochemical disease recurrence after radical prostatectomy often prompts salvage radiotherapy, but no studies to date have had sufficient numbers of patients or follow-up to determine whether… (More)

Active surveillance for prostate cancer: a systematic review of the literature.

Marc A Dall'Era, Peter C Albertsen, +7 authors Mark S. Soloway
European urology
2012

CONTEXT Prostate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal management of clinically localized, early-stage disease remains unknown, and profound quality of life… (More)

Obesity and prostate cancer: weighing the evidence.

Emma H Allott, Elizabeth M. Masko, Stephen J. Freedland
European urology
2013

CONTEXT Obesity and prostate cancer (PCa) affect substantial proportions of Western society. Mounting evidence, both epidemiologic and mechanistic, for an association between the two is of public… (More)

Lionel Lloyds Banez, Robert J Hamilton, +11 authors Stephen J. Freedland
JAMA
2007

CONTEXT Recent studies have suggested that obese men have lower serum prostate-specific antigen (PSA) concentrations than nonobese men. Because men with higher body mass index (BMI) have greater… (More)

Castration-resistant prostate cancer: AUA Guideline.

Michael S. Cookson, Bruce J. Roth, +9 authors Adam S. Kibel
The Journal of urology
2013

PURPOSE This Guideline is intended to provide a rational basis for the management of patients with castration-resistant prostate cancer based on currently available published data. MATERIALS AND… (More)

Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study Group

Stephen J. Freedland, William J. Aronson, +4 authors Martha K. Terris
Journal of clinical oncology : official journal…
2004

PURPOSE Given the limited information regarding the impact of obesity on treatment outcomes for prostate cancer, we sought to examine the relationship between body mass index (BMI) and cancer control… (More)

Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.

C. Díaz Rodríguez, Stephen J. Freedland, +5 authors Eugenia E. Calle
Cancer epidemiology, biomarkers & prevention : a…
2007

BACKGROUND Obesity has been associated with aggressive prostate cancer. The extent of this association, which varies by stage and grade, remains unclear. The role of recent weight change had not been… (More)

Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.

Roberto Lodeiro Muller, Leah Gerber, Daniel M Moreira, Gerald L. Andriole, Ramiro Castro-Santamaria, Stephen J. Freedland
European urology
2012

BACKGROUND Findings of studies on the association between androgens and prostate cancer (PCa) are mixed. Androgens may affect prostate-specific antigen (PSA) levels, thereby influencing biopsy… (More)

Filter Results:

Publication Year

Publication Type

Co-author

Journals and Conferences